Image Description

INVESTORS
& MEDIA

circle

2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013Press Release Archive
DateTitle 
May 15 2017Cytokinetics Announces Orphan Drug Designation for CK-2127107 for the Treatment of Spinal Muscular AtrophyPrinter Friendly Version
May 11 2017Cytokinetics to Hold Annual Meeting of StockholdersPrinter Friendly Version
May 08 2017Cytokinetics Announces Pricing of Public Offering of Common StockPrinter Friendly Version
May 08 2017Cytokinetics Announces Proposed Public Offering of Common StockPrinter Friendly Version
May 03 2017Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALSPrinter Friendly Version
May 01 2017Cytokinetics Announces Results from Dose Escalation Phase of COSMIC-HF Presented at Heart Failure 2017Printer Friendly Version
Apr 27 2017Cytokinetics, Inc. Reports First Quarter 2017 Financial ResultsPrinter Friendly Version
Apr 21 2017Cytokinetics Added to S&P SmallCap 600Printer Friendly Version
Apr 13 2017Cytokinetics to Announce First Quarter Results on April 27, 2017Printer Friendly Version
Mar 29 2017Cytokinetics to Present at the 16th Annual Needham Healthcare ConferencePrinter Friendly Version
Mar 29 2017Cytokinetics Announces Start of Second Cohort in Phase 2 Clinical Trial of CK-2127107 in Patients With Spinal Muscular AtrophyPrinter Friendly Version
Mar 23 2017Origent Data Sciences and Cytokinetics Advance Collaboration Intended to Validate Predictive Analytics Model in ALSPrinter Friendly Version
Mar 22 2017Cytokinetics Announces Preclinical Data for CK-2127107 Presented at MDA Scientific ConferencePrinter Friendly Version
Mar 20 2017Cytokinetics Announces Additional Results From COSMIC-HF Presented at ACC.17Printer Friendly Version
Mar 06 2017Cytokinetics Announces Presentation of Additional Results from COSMIC-HF at ACC.17Printer Friendly Version
Feb 28 2017Cytokinetics Joins Global Initiative to Recognize International Rare Disease DayPrinter Friendly Version
Feb 27 2017Cytokinetics to Present at March Investor ConferencesPrinter Friendly Version
Feb 16 2017Cytokinetics, Inc. Reports Fourth Quarter 2016 Financial ResultsPrinter Friendly Version
Feb 03 2017Cytokinetics to Announce Fourth Quarter Results on February 16, 2017Printer Friendly Version
Feb 02 2017Cytokinetics and Royalty Pharma Announce $100 Million Transaction for Omecamtiv MecarbilPrinter Friendly Version